July 2021 - Page 4 of 5 - BioMedWire (BMW)

FridayJul 09, 2021 2:00 pm

MSK Oncologists Share Approaches to Raise Survival Rates Among Soft Tissue Sarcoma Sufferers

Research has shown that nearly 50% of patients suffering from soft tissue sarcoma develop lung tumors. Presently, pulmonary metastasectomy, which is the surgical removal of lung tumors, is the primary treatment option for the disease as effective systemic treatments for metastatic soft tissue sarcoma are scarce. Despite this, guidelines for performing a pulmonary metastasectomy for soft tissue sarcoma don’t exist. and decisions to carry out the surgery are usually made on a person-to-person basis. During the 96th annual American Association for Thoracic Surgery meeting, scientists from the Memorial Sloan Kettering Cancer Center gave a presentation on prognostic factors and survival…

ThursdayJul 08, 2021 1:04 pm

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leveraging Similar Strategy as Leading Cannabis-Derived Compound Pharmaceutical Company

Jazz Pharmaceuticals’ acquisition of GW Pharma for $7.2 billion in February 2021 shows the massive potential of the drug development industry from naturally-derived compounds Tryp Therapeutics is following in the footsteps of GW with its innovative drug pipeline and the development of psilocybin-based compounds for the treatment of diseases with high unmet medical needs It is one of only a handful of companies moving into Phase 2a clinical trials with a psychedelic compound, and seeks to duplicate the success of GW As of 2020, the global biotech sector was valued at $753 billion. It is further projected to grow at…

ThursdayJul 08, 2021 10:00 am

Telehealth and Its Usefulness Beyond the Coronavirus Pandemic

The coronavirus pandemic forced many physicians to switch from in-person visits to telehealth in a bid to keep their patients safe and also prevent the virus from spreading. While this may have been a temporary solution for some, many herald it as the future, with one industry expert urging optometrists to continue utilizing the technology for their practices even as in-person visits resume. Christopher Wolfe recently gave a presentation at Vision Expo East in which he explained how at the onset of the coronavirus pandemic, instructions were given to not offer emergent or urgent care via telemedicine, revealing that in…

WednesdayJul 07, 2021 10:27 am

Predictive Oncology Inc. (NASDAQ: POAI) Companies Build New Labs, Expand Services for New Drug Discoveries

Two of Predictive Oncology’s four subsidiaries are constructing new Good Manufacturing Practices laboratories to offer additional services to customers With its new GMP lab, Soluble Biotech will provide customers formulations that can go directly to clinical trials, as well as manufacture proprietary media used in its chromatography kits TumorGenesis will use its GMP lab to produce its proprietary media that tricks tumor cells into growing outside the body the same as inside the body in addition to producing proteins and other biological products used in diagnosing, treating, and modifying tumor cells On the heels of raising $21.34 million and three…

WednesdayJul 07, 2021 9:45 am

New Blood Test Could Speed Up Diagnosis of Brain Cancer

A study conducted at the University of Strathclyde, in collaboration with clinicians from the Walton NHS Foundation Trust, the University of Liverpool and the Western General Hospital, has helped design a blood test that speeds up brain cancer diagnosis. This patented technology uses infrared light to produce a blood sample’s biosignature then utilizes artificial intelligence to check for any signs of cancer. The technology, which was reported in the “Nature Communications” journal, is being commercialized by ClinSpec Diagnostics Limited. The study was led by ClinSpec Diagnostics chief scientific officer Dr. Matthew J. Baker, who also happens to be a reader…

TuesdayJul 06, 2021 1:05 pm

The Coronavirus Pandemic Has Adversely Affected Genitourinary Cancer Patients

The findings of an initial virtual survey that was presented at the 2021 Genitourinary Cancers Symposium demonstrate that the coronavirus pandemic had a negative influence on patients who suffer from genitourinary malignancies. Genitourinary cancers are mainly found in the male reproductive system and the urinary system. These cancers include adrenal cancer, testicular cancer, urethral cancer, bladder cancer, kidney cancer, prostate cancer and cancers of the penis. The preliminary survey highlights that as a result of the pandemic, almost 12% of study participants missed at least one dose of a prescribed medication, 12% avoided making the trip to a pharmacy to…

TuesdayJul 06, 2021 9:15 am

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Featured in Stifel Report; Price Target Raised by C$12, Rated as Spec Buy

CYBN continues to demonstrate good progress with its preclinical activities on its novel drug programs, report observed Stifel also notes selecting indications with large patient pools, an understated market size, and potential for multiple synergies across development and distribution Report incorporates both CYB001 and CYB004 into valuation As Cybin (NEO: CYBN) (OTCQB: CLXPF), a biotechnology company focused on progressing psychedelic therapeutics, continues to develop its multimolecule strategy, people are paying attention. A recent Stifel report raised Cybin’s price target by C$12, up from C$4 to C$15, and maintained the company’s speculative buy rating (https://ibn.fm/HLcxX). “CYBN continues to demonstrate good progress…

FridayJul 02, 2021 3:00 pm

Researchers Find That Early Childhood Cancer Discovery May Prevent Metastasis

Researchers have made a new discovery in a fatal and aggressive childhood cancer known as Ewing sarcoma, which could possibly help hinder the spread of cancer cells. This new discovery offers new insights into what causes the process that enables cancer cells to survive as they travel through the bloodstream of an individual, spreading beyond the primary tumor site. Scientists with BC Cancer and the University of British Columbia have discovered that this particular type of cancer cells develop a shield that protects them from the bloodstream’s harsh environment as they metastasize. The researchers’ findings were reported in “Cancer Discovery.”…

FridayJul 02, 2021 10:54 am

Predictive Oncology Inc. (NASDAQ: POAI) Stands Strong as Innovator, Leader in Precision Medicine

Company plans to use proceeds from direct offering for business development, drug repurposing and discovery and expansion of its laboratory facilities POAI portfolio spans four different subsidiaries, including list of assets rivaling best operators in the space Predictive Oncology is strong standout in precision medicine Predictive Oncology (NASDAQ: POAI) has closed on its registered direct offering (https://ibn.fm/9buhx).The offering, which totaled $21.34 million, will be a boon for the knowledge-driven company as it continues its focus on applying artificial intelligence (“AI”) to personalized medicine and drug discovery. Operating in the AI space, the company is looking at almost vast potential as…

FridayJul 02, 2021 10:24 am

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Share its Drug Development Pipeline and the Company’s Progress in the Psych Investor Summit

Tryp Therapeutics will be participating in the second global Psych Investor Summit: Research and Development The virtual presentation is scheduled for July 7 from 11:50 a.m. to 12:50 p.m. EDT It will focus on the psychedelics industry, showcasing the latest research and development within the sector Mr. Greg McKee, Chairman and CEO of Tryp Therapeutics, will share information on the company, along with its drug development pipeline In an official statement dated June 24, 2021, Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) confirmed that it would participate in the Psych Investor Summit: Research and Development. The virtual event, scheduled on Wednesday,…

News and publishing service for medical and biotechnology related companies

Contact us: 512.354.7000

Month: July 2021

MSK Oncologists Share Approaches to Raise Survival Rates Among Soft Tissue Sarcoma Sufferers

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Leveraging Similar Strategy as Leading Cannabis-Derived Compound Pharmaceutical Company

Telehealth and Its Usefulness Beyond the Coronavirus Pandemic

Predictive Oncology Inc. (NASDAQ: POAI) Companies Build New Labs, Expand Services for New Drug Discoveries

New Blood Test Could Speed Up Diagnosis of Brain Cancer

The Coronavirus Pandemic Has Adversely Affected Genitourinary Cancer Patients

Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) Featured in Stifel Report; Price Target Raised by C$12, Rated as Spec Buy

Researchers Find That Early Childhood Cancer Discovery May Prevent Metastasis

Predictive Oncology Inc. (NASDAQ: POAI) Stands Strong as Innovator, Leader in Precision Medicine

Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) to Share its Drug Development Pipeline and the Company’s Progress in the Psych Investor Summit

Official NewsWire Relationships

BioMedWire Currently Accepts

BioMedWire

Company Search

Site Search